Focal hyperhidrosis

Venus Concept Inc. Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations

Retrieved on: 
Thursday, October 12, 2023
Venus, Senior, House of Medici, Domestic international sales corporation, R, Marketing, Growth, Focal hyperhidrosis, Corporate development, Management, Video game

TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the promotion of Dr. Hemanth Varghese to the newly created role of President and Chief Operating Officer (COO), reporting to Chief Executive Officer, Rajiv De Silva, effective October 16, 2023.

Key Points: 
  • Dr. Varghese joined Venus Concept in October of 2022 as President and Chief Business Officer.
  • His responsibilities were later expanded to include the Chief Innovation Officer role as well.
  • “I am delighted to have Hemanth as our new President & Chief Operating Officer, who will continue to build on our strong achievements to date with our new company strategy,” said Rajiv De Silva, Chief Executive Officer of Venus Concept.
  • “As we continue to reshape our international footprint, Kirk’s deep industry knowledge and experience in expanding international partner networks will be an important driver of future growth in the business.”

November International Hyperhidrosis Awareness Month: No Sweat, No Stress With the miraDry Treatment

Retrieved on: 
Thursday, October 31, 2019
Organ systems, Branches of biology, Hyperhidrosis, Thoracic surgery, Animal anatomy, Focal hyperhidrosis, Body fluids, Excretion, Reflexes, Perspiration, Stress

It manifests as extreme, uncontrollable sweating beyond what's considered "normal" or necessary as a reaction to heat, exercise or stress.

Key Points: 
  • It manifests as extreme, uncontrollable sweating beyond what's considered "normal" or necessary as a reaction to heat, exercise or stress.
  • The miraDry system is intended for use by health care professionals for treatment of primary axillary hyperhidrosis in adults.
  • miraDry and No Sweat No Stress is a trademark of miraDry, Inc. 2019 miraDry, Inc. All rights reserved.
  • Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device.Dermatol Surg.

Pharmacy Times Continuing Education™ Launches Hyperhidrosis Patient Perspective Video

Retrieved on: 
Monday, March 11, 2019
Health, Pharmaceutical, Other Science, Science, Managed care, Pharmacist, Health care, Health, Hyperhidrosis, Pharmacy school, Pharmacy, Pharmacy residency, Focal hyperhidrosis

Pharmacy Times Continuing Education (PTCE), a leader in continuing education (CE) for community, health-system, managed care and specialty pharmacists, launches Examining Hyperhidrosis (Excessive Sweating): A Managed Markets Update on New Treatments, Featuring a Patient Perspective.

Key Points: 
  • Pharmacy Times Continuing Education (PTCE), a leader in continuing education (CE) for community, health-system, managed care and specialty pharmacists, launches Examining Hyperhidrosis (Excessive Sweating): A Managed Markets Update on New Treatments, Featuring a Patient Perspective.
  • This patient perspective video features Maria Thomas, founder of the blog MyLifeAsAPuddle.com, who will provide the patient perspective to health care professionals about what its like to live with hyperhidrosis and what patients need when it comes to hyperhidrosis treatment options.
  • Pharmacy Times Continuing Education (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists.
  • PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).

Durham Startup Uses Holiday Deal Hype To Draw Attention To Excessive Sweating

Retrieved on: 
Friday, November 23, 2018
Hyperhidrosis, Thoracic surgery, Medicine, Perspiration, Deodorant, Anatomy, Biology, Focal hyperhidrosis, Compensatory hyperhidrosis

Hyperhidrosis is a condition marked by clinically excessive sweating.

Key Points: 
  • Hyperhidrosis is a condition marked by clinically excessive sweating.
  • The condition is common, affecting 1 in 5 teens and 8.8% of adults under 40.
  • Patients report severe negative psychological impacts from their excessive sweating, with 75% reporting that it is difficult to be in the public view.
  • Carpe is an antiperspirant company dedicated to offering relief from excessive sweating, especially in patients with hyperhidrosis.